Hood River Capital Management’s Revolution Medicines RVMD Stock Holding History

Hood River Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$31.9M	Buy	+170,422	New	+$24.9M	0.23%	110
2026 Q1	–	Sell	-945,585	Closed	-$75.3M	–	194
2025 Q4	$75.3M	Buy	945,585 +17,462	+2%	+$1.14M	0.83%	44
2025 Q3	$43.3M	Sell	928,123 -197,897	-18%	-$7.75M	0.51%	68
2025 Q2	$41.4M	Sell	1,126,020 -591,028	-34%	-$22.7M	0.58%	62
2025 Q1	$60.7M	Buy	1,717,048 +38,614	+2%	+$1.57M	1.04%	39
2024 Q4	$73.4M	Buy	1,678,434 +345,622	+26%	+$17.4M	1.08%	32
2024 Q3	$60.4M	Buy	1,332,812 +418,809	+46%	+$18.2M	0.98%	39
2024 Q2	$35.5M	Buy	+914,003	New	+$34.2M	0.74%	52

Other funds holding RVMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Hood River Capital Management's RVMD Position: Q2 2026 in Review

Hood River Capital Management opened a new position in Revolution Medicines (RVMD) in Q2 2026: 170,422 shares worth $31.9M. The stake represents 0.23% of the portfolio and ranks #110 among its holdings. This is a return to the name: Hood River Capital Management previously reported a position in RVMD as recently as Q4 2025.

Hood River Capital Management first reported a position in RVMD in Q2 2024 and has held it in 8 quarters since. The position peaked at $75.3M in Q4 2025. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

Hood River Capital Management held 170,422 shares of Revolution Medicines worth $31.9M as of Q2 2026.
Revolution Medicines was a new Hood River Capital Management position in Q2 2026.
Revolution Medicines made up 0.23% of Hood River Capital Management's portfolio in Q2 2026, its #110 holding.
Hood River Capital Management first reported a position in Revolution Medicines in Q2 2024 and has held it in 8 quarters since.
Hood River Capital Management's Revolution Medicines position peaked at $75.3M in Q4 2025.
691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Hood River Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.